Promosome uses its proprietary technology to produce and, with partners, to commercialize therapeutics for a range of under-served and / or under-treated conditions and diseases.
The technology for mRNA re-engineering (TEEs and RESCUE) and cell line development allow efficient production of difficult-to-express, high quality, therapeutically necessary proteins in commercial quantities. RESCUE provides an alternative to codon optimization to increase protein yield but with additional benefits to expression and safety of the resultant proteins.
Promosome technologies enhance protein synthesis by taking advantage of several features of the natural mRNA translation process.
Promosome seeks partners for licensing arrangements to produce biotherapeutic proteins. Contact us to discuss the possibilities.
Our innovative technologies will be new to many in the industry. We know there will be questions.